USP38 and gastric cancer: A growing body of evidence suggests that USP38 not only exhibits abnormal expression in various malignant cancers but is also closely involved in their initiation and progression, including gastric cancer, bladder cancer, and colorectal cancer, highlighting its crucial role in regulating the malignant progression of tumors.